Marlborough

Quest Diagnostics, a provider of diagnostic information services, Thursday unveiled its new clinical test laboratory in Marlborough with a ribbon-cutting ceremony attended by health care leaders and state officials, the company said.

The new $80-million Quest Diagnostics laboratory in Marlborough will be a hub of innovation, as well as the center for medical testing services for patients throughout New England, Quest CEO Steve Rusckowski told guests gathered to celebrate the opening of the Forest Street facility Thursday morning.

Marlborough-based Sunovion Pharmaceuticals said it has agreed to sell rights to its drug Xopenex Inhalation Solution (IS), used in the treatment of obstructive airway disease such as asthma.

IPG Photonics' 111,000 square foot expansion in Marlborough has been approved for $750,000 in tax credits through the state's Economic Development Incentive Program (EDIP).

Advanced Cell Technology has completed the initial phase of its clinical-trial treatment for Stargardt's macular degeneration (SMD), a genetic eye disorder that causes progressive vision loss, the Marlborough company announced.

Marlborough-based Boston Scientific Corp. (NYSE: BSX) has initiated a clinical trial to evaluate the safety and effectiveness of the Lotus Valve System, designed to treat patients with severe aortic stenosis, a condition that prevents the aorta from opening fully.

Marlborough-based ReWalk Robotics, which has commercialized a robotic exoskeleton for paraplegics, said a major German insurance company will reimburse a ReWalk system for personal use.

ReWalk Robotics, whose U.S. headquarters is in Marlborough, is still working to make its exoskeleton units widely available to people with spinal cord injuries. But on the heels of a successful IPO earlier this month, CEO Larry Jasinski said the company is already planning to bring mobility to a wider population of disabled people. In June, Rewalk received federal approval for its ReWalk Personal exoskeleton, designed to help people with spinal cord injuries walk. A robotic, wearable system, the ReWalk Personal provides power hip and knee motion, giving paraplegics the ability to walk.

Fidelity Bank of Fitchburg has agreed to pay $3.5 million toward a relief fund for Massachusetts investors who were defrauded by an alleged pyramid scheme involving TelexFREE of Marlborough, the secretary of state's office announced Monday.

ReWalk Robotics of Marlborough said it had closed its initial public offering of 3.45 million shares of stock, which includes 3 million offered on Monday and an additional 450,000 offered through an underwriters' option to purchase additional shares, the company said Wednesday